Neurologic morbidity and functional independence in adult survivors of childhood cancer.
Autorzy:
Vuotto SC; Department of Psychology, College of Mount Saint Vincent, Bronx, New York, USA. Wang M; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Okcu MF; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA. Bowers DC; University of Texas Southwestern Medical School, Dallas, Texas, USA. UllrichNJ; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA. Ness KK; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Li C; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Srivastava DK; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Howell RM; MD Anderson Cancer Center, Houston, Texas, USA. Gibson TM; National Cancer Institute, Division of Cancer Epidemiology & Genetics, Bethesda, Maryland, USA. Leisenring WM; Fred Hutchison Cancer Research Center, Seattle, Washington, USA. Oeffinger KC; Duke Univeristy School of Medicine, Duke Cancer Institute, Durham, North Carolina, USA. Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Krull KR; Department of Psychology & Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Brinkman TM; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Department of Psychology & Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Cerebral Vasculopathy in Children with Neurofibromatosis Type 1.
Autorzy:
Lehman LL; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. UllrichNJ; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Oct 23; Vol. 15 (20). Date of Electronic Publication: 2023 Oct 23.
A single-institution pediatric and young adult interventional oncology collaborative: Novel therapeutic options for relapsed/refractory solid tumors.
Autorzy:
Shaikh R; Department of Radiology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Weil BR; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Weldon CB; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Chen N; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. London WB; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Krush M; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Anderson M; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Gebhardt M; Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Church AJ; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. DuBois SG; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Spidle J; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Wall CB; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Feraco A; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. UllrichNJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.; Department of Neurology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Mack JW; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Mullen E; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Kamihara J; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Forrest S; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Shusterman S; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA. Alomari A; Department of Radiology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Padua H; Department of Radiology, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Rodriguez-Galindo C; Departments of Global Pediatric Medicine and Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. O'Neill AF; Department of Pediatric Oncology, Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Harvard Medical School, Boston, Massachusetts, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (12), pp. 13300-13308. Date of Electronic Publication: 2023 Jun 01.
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists.
Autorzy:
Merker VL; Department of Neurology and Cancer Center, Massachusetts General Hospital, 55 Fruit St, Yawkey 9E, Boston, MA, 02144, USA.; Center for Healthcare Organization and Implementation Research (CHOIR), VA Bedford Healthcare System, Bedford, MA, 01730, USA. Knight P; Children's Tumor Foundation, New York, NY, 10017, USA. Radtke HB; Children's Tumor Foundation, New York, NY, 10017, USA.; Division of Genetics, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. Yohay K; Department of Neurology, NYU Langone Health, New York, NY, 10017, USA. UllrichNJ; Department of Neurology, Boston Children's Hospital, Boston, MA, 02115, USA. Plotkin SR; Department of Neurology and Cancer Center, Massachusetts General Hospital, 55 Fruit St, Yawkey 9E, Boston, MA, 02144, USA. Jordan JT; Department of Neurology and Cancer Center, Massachusetts General Hospital, 55 Fruit St, Yawkey 9E, Boston, MA, 02144, USA. .
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Feb 10; Vol. 17 (1), pp. 44. Date of Electronic Publication: 2022 Feb 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Practical guidance for telemedicine use in neuro-oncology.
Autorzy:
Strowd RE; Department of Neurology and Internal Medicine, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest School of Medicine, Winston Salem, North Carolina, USA. Dunbar EM; Piedmont Brain Tumor Center, Atlanta, Georgia, USA. Gan HK; Medical Oncology, Austin Hospital, Heidelberg, Melbourne, Australia. Kurz S; Brain and Spine Tumor Center at the Perlmutter Cancer Center, Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA. Jordan JT; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. Mandel JJ; Baylor College of Medicine, Department of Neurology and Neurosurgery, Houston, Texas, USA. Mohile NA; Department of Neurology and Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York, USA. Nevel KS; Indiana University School of Medicine and Indiana University Health, Brain Tumor Center, Department of Neurology, Indianapolis, Indiana, USA. Taylor JW; Department of Neurology and Neurological Surgery, University of California, San Francisco, California, USA. UllrichNJ; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Welch MR; Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital, New York, New York, USA. Wasilewski A; University of Rochester Medical Center, Rochester, Minnesota, USA. Mrugala MM; Mayo Clinic College of Medicine and Science, Mayo Clinic, Phoenix/Scottsdale, Arizona, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 Jan 17; Vol. 9 (2), pp. 91-104. Date of Electronic Publication: 2022 Jan 17 (Print Publication: 2022).
The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research.
Autorzy:
Radtke HB; Children's Tumor Foundation, New York, NY, USA. .; Medical College of Wisconsin, Milwaukee, WI, USA. . Klein-Tasman BP; University of WI - Milwaukee, Milwaukee, WI, USA. Merker VL; Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA, USA. Knight P; Children's Tumor Foundation, New York, NY, USA. UllrichNJ; Boston Children's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA. Jordan JT; Massachusetts General Hospital, Boston, MA, USA. Korf B; University of Alabama At Birmingham, Birmingham, AL, USA. Plotkin SR; Massachusetts General Hospital, Boston, MA, USA.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2021 Feb 01; Vol. 16 (1), pp. 61. Date of Electronic Publication: 2021 Feb 01.
Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1.
Autorzy:
UllrichNJ; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts. Payne JM; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. Walsh KS; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC. Cutter G; School of Public Health, University of Alabama, Birmingham, Alabama. Packer R; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC. North K; Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia. Rey-Casserly C; Department of Psychiatry, Boston Children's Hospital, Boston, Massachusetts.
Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1.
Autorzy:
Payne JM; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. Hearps SJC; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia. Walsh KS; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC. Paltin I; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Barton B; Kids Neuroscience Centre, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.; Children's Hospital Education Research Institute, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.; The University of Sydney Children's Hospital Westmead Clinical School, University of Sydney, Westmead, New South Wales, Australia. UllrichNJ; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts. Haebich KM; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia. Coghill D; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia. Gioia GA; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC. Cantor A; Department of Preventative Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Cutter G; School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama. Tonsgard JH; Division of Neurology, The University of Chicago Medicine Comer Children's Hospital, Chicago, Illinois. Viskochil D; Department of Genetics, University of Utah, Salt Lake City, Utah. Rey-Casserly C; Center for Neuropsychology, Boston Children's Hospital, Boston, Massachusetts. Schorry EK; Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. Ackerson JD; Department of Psychology, University of Alabama at Birmingham, Birmingham, Alabama. Klesse L; Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas. Fisher MJ; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Gutmann DH; Department of Neurology, Washington University School of Medicine, St Louis, Missouri. Rosser T; Department of Neurology, Children's Hospital of Los Angeles, Los Angeles, California. Packer RJ; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC. Korf B; Department of Genetics, University of Alabama at Birmingham, Birmingham, Alabama. Acosta MT; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC.; National Institutes of Health, National Human Genome Research Institute, Bethesda, Maryland. North KN; Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Pain affect disrupted in children with posterior cerebellar tumor resection.
Autorzy:
Silva KE; Center for Pain and the Brain Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Harvard Medical School Boston Massachusetts 02215. Rosner J; Center for Pain and the Brain Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Harvard Medical School Boston Massachusetts 02215. UllrichNJ; Department of Neurology Boston Children's Hospital Harvard Medical School Boston Massachusetts 02115.; Department of Hematology/Oncology Boston Children's Hospital Harvard Medical School Boston Massachusetts 02115.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts 02115. Chordas C; Department of Hematology/Oncology Boston Children's Hospital Harvard Medical School Boston Massachusetts 02115. Manley PE; Department of Hematology/Oncology Boston Children's Hospital Harvard Medical School Boston Massachusetts 02115.; Dana-Farber/Boston Children's Cancer and Blood Disorders Center Boston Massachusetts 02115. Moulton EA; Center for Pain and the Brain Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Harvard Medical School Boston Massachusetts 02215.
Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer.
Autorzy:
UllrichNJ; Department of Neurology, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts 02115, USA. nicole.ullrich@childrens.harvard.edu
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
